In a nutshell, tau pathology, white matter integrity loss, cortical atrophy patterns, genetic mutation, low PET metabolic activity, and early cognitive test results are the integrated factors in prognosis when neurodegenerative course prediction is made in PPA. This evidence concerns the gene MAPT and primary progressive aphasia.